Back to Search Start Over

Production of a novel recombinant brown spider hyaluronidase in baculovirus-infected insect cells.

Authors :
De-Bona E
Chaves-Moreira D
Batista TBD
Justa HCD
Rossi GR
Antunes BC
Matsubara FH
Minozzo JC
Wille ACM
Veiga SS
Senff-Ribeiro A
Gremski LH
Source :
Enzyme and microbial technology [Enzyme Microb Technol] 2021 May; Vol. 146, pp. 109759. Date of Electronic Publication: 2021 Feb 11.
Publication Year :
2021

Abstract

Hyaluronidases are low expressed toxins of brown spider venoms, but, as highly active molecules, they present an important role as spreading factors. By degrading extracellular matrix components, these enzymes favor the diffusion of toxins in the affected tissue and at systemic level. Here, a novel isoform of hyaluronidase of Loxosceles intermedia Mello-Leitão (1934) venom was cloned, expressed in a baculovirus-insect cell expression system and fully active purified. This recombinant enzyme, named LiHyal2 (Loxosceles intermedia Hyaluronidase isoform 2), shares high identity with hyaluronidases of other spiders and scorpions. The catalytic and sugar binding amino acid residues are conserved in LiHyal2, human, and honeybee venom hyaluronidases and the molecular model of LiHyal2 shares major similarities with their crystal structures, including the active site. LiHyal2 was expressed as a 45 kDa protein and degraded hyaluronic acid (HA) and chondroitin sulphate as demonstrated by HA zymography and agarose gel electrophoresis. Lectin blot analysis revealed that LiHyal2 is post-translationally modified by the addition of high mannose N-linked carbohydrates. In vivo experiments showed that LiHyal2 potentialize dermonecrosis and edema induced by a recombinant phospholipase-D (PLD) of L. intermedia venom, as well as enhance the increase in capillary permeability triggered by this PLD, indicating that these toxins act synergistically during envenomation. Altogether, these results introduce a novel approach to express spider recombinant toxins, contribute to the elucidation of brown spider venom mechanisms and add to the development of a more specific treatment of envenomation victims.<br /> (Copyright © 2021 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1879-0909
Volume :
146
Database :
MEDLINE
Journal :
Enzyme and microbial technology
Publication Type :
Academic Journal
Accession number :
33812558
Full Text :
https://doi.org/10.1016/j.enzmictec.2021.109759